Confluent CFO sells 29,996 shares at $30.67

Confluent, Inc. Chief Financial Officer Rohan Sivaram sold 29,996 shares of Class A Common Stock in an open-market transaction at an average price of $30.67 per share.

Accepted by SEC EDGAR 03/13/2026 - 07:53 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Confluent, Inc. Chief Financial Officer Rohan Sivaram sold 29,996 shares of Class A Common Stock in an open-market transaction at an average price of $30.67 per share. The sale took place on March 12, 2026, under a pre-arranged Rule 10b5-1 trading plan dated December 11, 2025.

Following this transaction, Sivaram directly holds 531,971 shares of Confluent stock, which includes 1 share purchased under the company’s 2021 Employee Stock Purchase Plan on March 12, 2026. The sale represents only a small portion of his overall reported holdings.

Insider Trade Summary 10b5-1

Net Seller: 29,996 shares

Net Sell 1 txn

Insider Sivaram Rohan

Role CHIEF FINANCIAL OFFICER

Sold 29,996 shs ($920K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	29,996	$30.67	$920K

Holdings After Transaction: Class A Common Stock — 531,971 shares (Direct)

Footnotes (3)

1. F1. Shares sold pursuant to a 10b5-1 trading plan dated December 11, 2025.
2. F2. The shares were sold at prices ranging from $30.66 to $30.68. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. Incudes 1 share purchased under the Issuer's 2021 Employee Stock Purchase Plan on March 12, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Confluent (CFLT) report for CFO Rohan Sivaram?

Confluent reported that CFO Rohan Sivaram sold 29,996 shares of Class A Common Stock. The shares were sold in an open-market transaction at an average price of $30.67 per share on March 12, 2026, according to a Form 4 filing.

How many Confluent (CFLT) shares does CFO Rohan Sivaram hold after the sale?

After the reported sale, CFO Rohan Sivaram directly holds 531,971 Confluent shares. This total includes 1 share purchased under Confluent’s 2021 Employee Stock Purchase Plan on March 12, 2026, as disclosed in the Form 4 footnotes.

Was the Confluent (CFLT) CFO’s share sale made under a 10b5-1 trading plan?

Yes. The Form 4 footnotes state that the shares were sold pursuant to a Rule 10b5-1 trading plan dated December 11, 2025. Such pre-arranged plans schedule trades in advance, making the timing more routine and less discretionary.

At what prices did Confluent (CFLT) CFO Rohan Sivaram sell his shares?

The filing reports an average sale price of $30.67 per share. Footnotes explain that individual trades occurred in a price range between $30.66 and $30.68, and detailed breakdowns are available upon request from the reporting person.

Did the Confluent (CFLT) CFO also acquire any shares on the Form 4 date?

Yes. A footnote explains that Sivaram’s reported holdings include 1 share purchased under Confluent’s 2021 Employee Stock Purchase Plan on March 12, 2026. This purchase is small relative to his overall direct ownership position.

How significant is the Confluent (CFLT) CFO’s reported share sale relative to his holdings?

The sale of 29,996 shares is modest compared to Sivaram’s remaining 531,971 directly held shares. This indicates he retained the large majority of his disclosed position after the transaction, according to the Form 4 data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sivaram Rohan

(Last) (First) (Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVENUE

(Street)

MOUNTAIN VIEW CA 94041

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF FINANCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/12/2026		S(1)		29,996	D	$30.67(2)	531,971(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold pursuant to a 10b5-1 trading plan dated December 11, 2025.

2. The shares were sold at prices ranging from $30.66 to $30.68. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Incudes 1 share purchased under the Issuer's 2021 Employee Stock Purchase Plan on March 12, 2026.

	/s/ Weilyn Wood, Attorney-in-Fact	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.